Stereotaxis

Stereotaxis

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases. Learn more

Launch date
Employees
Market cap
€169m
Enterprise valuation
€166m (Public information from Sep 2024)
Saint-Louis Département de Saint-Louis (HQ)
Authorizing premium user...